Clinical trial Recruiting at 2 sites Observational Ages 18 and up

How kidney transplant patients feel about using artificial intelligence in medicine

Official title: Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

Run by Paris Translational Research Center for Organ Transplantation · NCT07600541 · Data updated 2026-11-12

This international survey asks adults who have had a kidney transplant how they feel about AI tools that predict graft loss and what it might mean for their daily care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorParis Translational Research Center for Organ Transplantation
Academic / other
Locations2 sites (Paris, Île-de-France Region and 1 other locations)
StatusRecruiting
StartedApril 15, 2026
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedMay 20, 2026
Trial IDNCT07600541 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who have received a kidney transplant and can read French or English, with access to the online questionnaire and able to provide electronic consent.

Probably not a fit

Individuals unwilling or unable to engage with online questionnaires or provide electronic consent may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, multicenter survey explores kidney transplant recipients' views on artificial intelligence in medicine, focusing on a system that estimates the risk of graft loss. Participants complete an online questionnaire in French or English, with responses analyzed using large language models and human review to ensure accuracy. The goal is to understand expectations, concerns, and the potential impact of AI-driven predictions on patient care, ethics, and transparency in transplantation. The study builds on existing predictive tools like iBox and seeks patient-centered insights to guide responsible deployment of AI in this field. Recruitment includes adult participants at selected centers in France and the United States.

Why it matters

Potential benefit: If successful, the study could inform how AI tools are communicated and integrated in transplant care to better align with patient values and concerns.

How similar studies have gone: Prior work on AI in transplantation has focused on clinical performance; patient-perception studies are less common but are increasingly recognized as important for ethical deployment.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Inclusion criteria

  * Age ≥ 18 years
  * Fluency in French or English
  * Electronic consent given
* Exclusion criteria

  * Severe cognitive impairment preventing comprehension
  * Technical inability to access the questionnaire

Where it's running

  • Le flambeau de la vie
    Paris, Île-de-France Region, France
    Recruiting
  • Nice Pasteur
    Paris, Île-de-France Region, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.